Nordwand Advisors’s AdaptHealth AHCO Stock Holding History

Nordwand Advisors’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-300	Closed	-$3.65K	–	125
2023 Q2	$3.65K	Hold	300	–	–	﹤0.01%	107
2023 Q1	$3.73K	Buy	+300	New	+$5.52K	﹤0.01%	113

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Nordwand Advisors's AHCO Position: Q3 2023 in Review

Nordwand Advisors sold out of AdaptHealth (AHCO) in Q3 2023, closing a stake of 300 shares — an estimated $3.65K sold.

Nordwand Advisors first reported a position in AHCO in Q1 2023 and held it in 2 quarters. The position peaked at $3.73K in Q1 2023. 191 funds tracked by Wall St. Rank hold AHCO as of Q3 2023.

Nordwand Advisors reported no remaining AdaptHealth position as of Q3 2023 after selling out during the quarter.
Nordwand Advisors sold 300 AdaptHealth shares in Q3 2023, an estimated $3.65K.
Nordwand Advisors first reported a position in AdaptHealth in Q1 2023 and held it in 2 quarters.
Nordwand Advisors's AdaptHealth position peaked at $3.73K in Q1 2023.
191 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2023.

Based on Nordwand Advisors's 13F filing for Q3 2023, filed 27 Oct 2023.